✦ LIBER ✦

Parkinson's disease dementia: at the crossroads of α-synuclein, tau and amyloid-β

✍ Scribed by Irwin, David; Lee, V.; Trojanowski, J.

Book ID: 122134151
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 49 KB
Volume: 35
Category: Article
ISSN: 0197-4580
DOI: 10.1016/j.neurobiolaging.2014.01.070

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Parkinson's disease dementia: convergenc

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

✍ Irwin, David J.; Lee, Virginia M.-Y.; Trojanowski, John Q. 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 728 KB

CSF α-synuclein, tau, and amyloid β in P

CSF α-synuclein, tau, and amyloid β in Parkinson's disease

✍ Min Shi; Jing Zhang 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 36 KB

CSF α-synuclein, tau, and amyloid β in P

CSF α-synuclein, tau, and amyloid β in Parkinson's disease – Authors' reply

✍ Brit Mollenhauer; Walter J Schulz-Schaeffer; Michael G Schlossmacher 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 45 KB

α-Synuclein and dopamine at the crossroa

α-Synuclein and dopamine at the crossroads of Parkinson's disease

✍ Lara Lourenço Venda; Stephanie J. Cragg; Vladimir L. Buchman; Richard Wade-Marti 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 529 KB

Tau and α-synuclein in susceptibility to

Tau and α-synuclein in susceptibility to, and dementia in, Parkinson's disease

✍ An Goris; Caroline H. Williams-Gray; Graeme R. Clark; Thomas Foltynie; Simon J. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

Cerebrospinal fluid Tau/α-synuclein rati

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

✍ Lucilla Parnetti; Davide Chiasserini; Gianni Bellomo; David Giannandrea; Claudia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB

## Abstract Although alpha‐synuclein is the main constituent of Lewy bodies, cerebrospinal fluid determination on its own does not seem fundamental for the diagnosis of synucleinopathies. We evaluated whether the combination of classical biomarkers, Aβ~1–42~, total tau, phosphorylated tau, and α‐sy